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Abstract 
Ring closure and ring opening reactions are in many cases useful synthetic procedures in organic 
chemistry. They allow the preparation of complex molecules with high stereoselectivity and 
good yields. Mechanistic and theoretical studies have been carried out on the transformation of 
2-aminopyrimidines into imidazo[1,2-c]pyrimidines and guanidines, respectively, through ring 
closure and ring opening reactions, as well as the transamidation reactions through the ring 
closure and ring opening of guanidine derivatives, which constitute novel synthetic methods. 
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Introduction 
 
In the course of a project directed towards the synthesis of imidazo[1,2-a]pyrimidines using 2-
aminopyrimidines as starting materials, we found novel synthetic methods to obtain imidazo[1,2-
c]pyrimidines and guanidines, which took place through ring closure and ring opening reactions. 
As an extension of these studies, we also observed an unprecedented transamidation reaction of 
N-carboxamidomethyl-N´tosylguanidines under mild conditions. 
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1. Novel synthesis of imidazo[1,2-c]pyrimidines  
 
During the preparation of a series of imidazo[1,2-a]pyrimidines for a pharmaceutical study, we 
obtained our first unintended result, the discovery of a new synthetic method of imidazo[1,2-
c]pyrimidines.1 The synthetic target of our project was the preparation of polyfunctionalized 
imidazo[1,2-a]pyrimidines with an amino group at the C-2, structurally related to Enviroxime, a 
benzimidazole derivative with strong in vitro antirhinoviral activity2 (Figure 1). Imidazo[1,2-
a]pyrimidines are important compounds in pharmaceutical chemistry as antiviral agents,3a 
inotropic and β-blocking agents,3b antibacterials,3c antifungal agents,3d benzodiazepine receptor 
agonists,3e and calcium channel blockers.3f The synthesis of imidazo[1,2-a]pyrimidines has been 
widely investigated and one of the most common strategies uses 2-aminopyrimidine as the 
starting material.4 However, no synthesis of 2-amino substituted imidazo[1,2-a]pyrimidines were 
found in the literature, and we chose the method used by Bochis5 and Hamdouchi6 for the 
preparation of imidazo[1,2-a]pyridines, starting from 2-aminopyrimidines.  
 
 
 
Figure 1 
 
 Accordingly with the above procedure, the reaction of the 2-p-tosylaminopyrimidine 2 
with the appropriate bromoacetamides 3 in the presence of Hünig´s base in DMF provided the 
corresponding 2-tosylimino-1-substituted dihydropyrimidines 4 as major products. The higher 
yields in the endocyclic nitrogen alkylation in comparison with the N-exocyclic alkylation are in 
accordance with the literature, as it has been reported that 2-aminopyrimidines are predominantly 
alkylated at the ring nitrogen except when steric requirements of the alkyl halide are great 
enough to direct the reaction to the exocyclic nitrogen.7 On the other hand, it is known that 
acylations normally occur at the exocyclic nitrogen.8 When the alkylated products 4 were heated 
at reflux in trifluoroacetic anhydride as solvent, the imidazo[1,2-a]pyrimidines 5 were obtained. 
However, in the reaction of 2B,C with 3b-f instead of the expected compounds 4, the 
hexahydroimidazo[1,2-c]pyrimidines 6 were isolated. On the other hand, by heating at reflux 
imidazo[1,2-c]pyrimidines 6 with trifluoroacetic anhydride in dichloromethane and TsOH as 
catalyst, the imidazo[1,2-a]pyrimidines 5 were afforded (Scheme 1). 
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Scheme 1 
 
 Compounds 6 were characterized spectroscopically. The imidazo[1,2-c]pyrimidines have 
two stereocenters with C8a-H and C3-H in trans disposition. The X-ray crystallographic analysis of 
a single crystal of 6Ac confirmed the stereochemistry (Figure 2). 
 
 
Figure 2 
 
 Imidazo[1,2-c]pyrimidine structural moiety presents potential interest as may be regarded 
as a 3-deazapurine with a bridgehead nitrogen atom in which N3 and C3a are interchanged. 
Several methods have been applied for the synthesis of imidazo[1,2-c]pyrimidines and the most 
frequently developed procedure involves the condensation of 4(6)-aminopyrimidine 
derivatives.4a,f To the best of our knowledge, our finding was the first example of a synthesis of 
imidazo[1,2-c]pyrimidines starting from 2-aminopyrimidine. 
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 The formation of the imidazo[1,2-c]pyrimidines 6 is the result of a Michael addition of the 
carboxamide group to the α,β-unsaturated imine system. The trans disposition of the H3 and H8a 
hydrogens confirms that the addition of the amide to the unsaturated imine is diastereoselective 
with the nucleophilic attack occurring preferentially on the opposite face to the aryl substituent at 
C3 (Scheme 2). 
 
 
 
Scheme 2 
 
 The most relevant aspects on which we would like to emphasize of this novel synthetic 
method of imidazo[1,2-c]pyrimidines through an unusual Michael addition are the following: 
1) A carboxamide group as nucleophile  
2) An α,β-unsaturated imine as electrophile  
 
1) A carboxamide group as nucleophile 
The nucleophilic attack of a carboxamide to an unsaturated system is not very frequent and the 
most common examples reported in the literature are intramolecular and intermolecular additions 
to C=N double bonds. For instance, strongly electrophilic iminium species derived from 
pirrolidine, which undergo cyclization via intramolecular attack of an amido group9,10 (Scheme 
3).  
 
 
Scheme 3 
 
 A similar mechanism, under anhydrous acidic conditions, has been postulated for the 
formation of a polyheterocyclic compound in the reaction of glutaraldehyde with pipecotamide 
(2-piperidinecarboxamide) (Scheme 4).11 
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Scheme 4 
 
 Finally, examples of a nucleophilic attack of a carboxamide group to a C=N are found in 
the field of antibiotics. In the Scheme 5 it is shown the synthesis of the hetacillin, prepared by the 
reaction of acetone on the commercially penicillin, ampicillin,12 and the synthesis of 
rolitetracycline, a derivative of tetracycline obtained via intermolecular addition of a 
carboxamide group to the iminium salt of pyrrolidine and formaldehyde.13 
 
 
 
Scheme 5 
 
2)  An α,β-unsaturated imine as electrophile 
The other aspect of this novel synthetic method of imidazo[1,2-c]pyrimidines is the 1,4-
nucleophilic addition to an α,β-unsaturated imine. One of the most intriguing and unexplored 
fields of nucleophilic addition reactions involves a conjugated addition to α,β-unsaturated imino 
compounds and very few examples of such additions are found in the literature. A first example 
of a Michael-type addition to an unsaturated imine system is the condensation of 
triethylphosphite in presence of formic acid with aldimines, promoted by initial protonation at 
nitrogen and resulting in the formation of 1,4-adducts.14 Similar additions of “in situ” generated 
diethyl trimethylsilyl phosphite to N-arylimines of cinnamaldehyde afford 1,2- adducts as sole 
products, mixtures of 1,2 and 1,4 adducts or exclusively 1,4 adducts, depending on the 
substitution pattern.15 Analogously, highly regioselective 1,2-additions are achieved with 
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organolanthanum reagents generated in situ from lanthanide trichloride and alkyl lithium or allyl 
magnesium16 (Scheme 6). 
 
 
 
Scheme 6 
 
 Recently, double nucleophilic addition reactions in the presence of Lewis acids of ketene 
silyl acetals, allylstannanes and thiols to α,β-unsaturated imines, via intermediary imino species, 
which are relatively difficult to be isolated and purified have been reported17 (Scheme 7). 
 
 
 
Scheme 7 
 
 In conclusion, we have presented a novel synthetic method of imidazo[1,2-c] pyrimidines 
6 and a facile preparation of imidazo[1,2-a]pyrimidines 5 from N-alkylated 2-
tosyliminodihydropyrimidines 4, easily obtained from 2-aminopyrimidine. The potential 
antiinflamatory activity of imidazo[1,2-c] pyrimidines 618 and imidazo[1,2-a] pyrimidines 519 has 
been studied showing interesting pharmacological profiles. Theoretical studies on the ring 
closure of some dihydropyrimidines to afford imidazo[1,2-c]pyrimidines through the 1,4-
addition of a nucleophilic carboxamide group are in progress. 
 
 
2. Synthesis of guanidines by ring opening of dihydropyrimidines 
 
As imidazo[1,2-c]pyrimidines I were obtained from 2-tosylimino-1-carbamoyl-
methylpyrimidines II by an unsual intramolecular Michael addition of the carboxamide group to 
the α,β-unsaturated imino system, we were intrigued to see if intermolecular Michael additions, 
under controlled conditions, with primary amines would take place on similar 1,2-
dihydropyrimidine systems II affording structures III. Moreover, since we found biological 
activity in imidazo[1,2-c]pyrimidines I,18 we considered it would be interesting the preparation 
of analogous molecules III with the functionality of the imidazo[1,2-c]pyrimidines I, but without 
the imidazo ring (Figure 3).  
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Figure 3 
 
 It is known that at least two categories of pyrimidines are prone to ring fission, albeit by a 
variety of mechanisms. The first group has decreased aromaticity because of a fixed system of 
double bonds as in 1,2-dihydro-2-imino-1-methylpyrimidines which undergoes Dimroth 
rearrangement involving ring fission in aqueous solution. The second group comprises 
pyrimidine itself in which the π layer is depleted by the ring nitrogen atoms and more in 
particular, those pyrimidines bearing an additional electron-withdrawing group (Scheme 8).20 
 
 
 
Scheme 8 
 
 In spite of the precedented regards, we were interested in investigating the reactivity of 2-
tosyliminodihydropyrimidines with primary amines. The substrates for this study were 4Aa and 
the analogous N-alkylated dihydropyrimidines containing a 1,4-disubstituted benzene ring 7b-f, 
prepared for a pharmacological study.21 The reaction of the alkylated products 4Aa and 7b-f with 
methylamine (g) at –40 ºC provided guanidines 8a-f in high yields (70-90%), along with (Z)-3-
methylamino-2-propenal 9 (5-8%) (Scheme 9).22  
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Scheme 9 
 
 Numerous natural and non-natural guanidine derivatives have shown biological activity, 
making these compounds targets for drugs design and discovery,23 sulfonylguanidines are 
specially of great interest in medicinal chemistry.24 Classically, guanidines are obtained through 
intermediates such as thioureas, carbodiimides, chloroformamidines, dichloroisocyanides, 
carboxamidines or cyanamides and through Mitsunobu protocol.25  
 The formation of guanidines 8 was explained by the nucleophilic addition of methylamine 
at the ring carbon (C6) of the 2-tosyliminopyrimidines 4Aa and 7b-f. Concomitant ring opening 
and further attack of the amine at C4 followed by N3-C4 bond cleavage would give guanidines 8 
and the intermediate 11 isolated as the hydrolysed product (Z)-3-methylamino-2-propenal 9 
(Scheme 10).  
 
 
 
Scheme 10 
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 Inspection of the literature has shown that ring fission of pyrimidine systems was 
extensively studied in the sixties,20 and a close analogy with our result is the reaction of 1,2-
dihydro-2-imino-1-methylpyrimidine with butylamine, studied by Brown,26 who obtained 1,3-
dibutyliminopropane and “postulated” the loss of methylguanidine, which was “not isolated” 
(Scheme 11).  
 
 
 
Scheme 11 
 
 In summary, the transformation of the 1,2-dihydro-2-toluenesulfonylimino- pyrimidines 
4Aa and 7b-f into guanidines 8a-f, initiated by the ring opening of the dihydropyrimidine moiety 
constitutes a simple and efficient route to important substituted tosylguanidine derivatives. 
 
 
3. New transamidation reaction through ring closure and ring opening of 
guanidine derivatives 
 
In order to obtain a deeper insight of the transformation of compounds 4Aa and 7b-f into 
guanidines 8a-f by treatment with methylamine, which we have previously observed, and to 
extend the scope of this finding, we studied the behaviour of the dihydropyrimidine 4Aa with 
other alkyl primary amines as n-propyl and n-butylamine at room temperature. In these reactions 
the expected guanidine 8a was isolated in good yields (70 – 75 %), however, surprisingly, when 
the reaction conditions were changed and dihydropyrimidine 4Aa was treated with the same 
amines under heating, the unexpected guanidines 12a-c, resulting from a transamidation reaction, 
were obtained in moderate to good yield (50-64%). Moreover, treatment of the guanidine 8a with 
methylamine (g) (acetonitrile, 50 ºC, sealed tube), and propyl and butylamine (50 ºC), afforded 
the same transamidated products 12a-c with good yields. To obtain unequivocal evidence for the 
structure of compounds 12 and confirm the proposed transamidation reaction, guanidines 12 
were alternatively synthesized from the ester 13 by treatment with alkyl amine at room 
temperature (Scheme 12).27 
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Scheme 12 
 
 This unprecedented intermolecular transamidation reaction of guanidines 8 into guanidines 
12 represents a new and important synthetic strategy. Transamidation is a useful tool in synthetic 
organic chemistry. Direct transamidation reactions with amines intramolecularly or 
intermolecularly are known to be difficult as the amide functional group is resonance stabilized 
and they are restricted to special conditions and requirements. In the literature there are examples 
of these reactions, but all of them take place under special requirements such as ring expansion 
of lactams28 and oxosultams,29 lower carboxamides,30 intramolecular processes,31 activated 
amides,32 catalytic conditions (enzymatic,33 Lewis acid catalysis34) or high temperatures,35 and 
critical pH.36 Transamidation reactions with N-sulfonamide linkers have been applied in peptide 
synthesis in solid phase.37  
 The formation of guanidines 12, which we obtained by a smooth intermolecular 
transamidation, was explained to occur through the intermediacy of a CO-N-SO2 substructure by 
a mechanism which supposes a sulphonamide-amide intramolecular interaction and formation of 
the imidazolidinone 14 (Scheme 13).  
 
 
 
Scheme 13 
 
 The proposed mechanism through a ring closure and subsequent ring opening by the 
nucleophilic attack of the amine to afford guanidines 12 agrees with mechanisms reported in the 
literature for known transamidations, such as intramolecular transamidation reaction with amides 
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containing the structural element CO-N(CH3)-N,38 intermolecular transamidation promoted by 
intramolecular activation31e or the ring opening of the highly strained and reactive oxosultams.29 
To confirm the postulated mechanism, we examined the reaction of dihydropyrimidine 4Aa and 
guanidine 8a with secondary amines (Me2NH, Et2NH, i-Pr2NH). In this case the imidazolidin-4-
one 14 was obtained and no transamidated guanidine was isolated (Scheme 14). 
 
 
 
Scheme 14 
 
 Interestingly, our result is different from Brown´s result,26 who obtained the Dimroth 
rearrangement product 15 in the reaction of 2-imino-dihydropyrimidine with diethylamine. The 
formation of 2-methylaminopyrimidine 15 is explained by the author via the intermediates 16 
and 17. The loss of methylguanidine in the final step of primary amines addition through the 
intermediate 18 would be impossible according to Brown in the case of secondary amines, where 
the intermediate 19 would be involved and the recyclization step takes place from the 
intermediate 17 affording the Dimroth compound. Probably, in our case the electron-
withdrawing effect of the tosyl group makes difficult the nucleophilic attack of the nitrogen 
necessary for the recyclization step (Scheme 15).  
 
 
 
Scheme 15 
 
 In order to verify whether the cyclization product 14 could be the key intermediate in the 
transformation of dihydropyrimidine 4Aa and guanidine 8a into the transamidation compounds 
12, we investigated the reaction of 14 with primary alkyl amines (methyl, propyl and 
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butylamine) at reflux temperature. In all cases, guanidines 12a-c were quantitatively obtained. 
However, in the reaction of 14 with a secondary amine as dimethylamine under the same 
conditions the starting material was recovered even under extended reaction times and no traces 
of compound 12d could be detected (Scheme 16).  
 
 
 
Scheme 16 
 
 Actually, to the best of our knowledge, the transformation of guanidines 8 into guanidines 
12 is a novel example of a transamidation reaction under mild conditions. It may be considered 
as a simple, efficient and facile method for the direct conversion of non activated N-
unsubstituted carboxamides to secondary carboxamides. Theoretical and synthetic studies are in 
progress in order to investigate the scope and limitations of this useful transformation. 
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